M
Medivation
Biopharmaceutical company focused on the rapid development of small molecule drugs to treat serious diseases
At a glance
- Founded
- 2003
- Headquarters
- San Francisco, United States
- Listing
- Public via SPAC 2004
- Sector
- Biotech & Life Sciences
- Power Law
- Decacorn$10B+ valuation tierThoroughbred$100M+ revenue
Knowledge graph
More headlines
Investors
From Dealroom's funding and investor records, grouped by the round each investor first entered.
Series B and later2 investors entered at this stage
- UCUniversity of California
- LALos Angeles
Source: Dealroom Talent Intelligence.
Alumni founders
Former Medivation employees who went on to found companies, sorted by Dealroom signal score.
NBNuvation BioEst. 2018
David HungM.D.United States
ATAvenzo TherapeuticsEst. 2022
David HungUnited StatesGlobal footprint
team presence
Patents
24 active patent families included in this estimate.
A patent family groups patent filings for the same invention. Source: Dealroom · PatSnap.
Market sentiment
An AI-synthesised read of the highest-engagement posts about Medivation on X, ranked by likes and reposts, corporate channels excluded.
Reading the room on X — pulling top posts and synthesizing themes…
Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour
See Medivation on the full Dealroom platform
Live deal flow, founder pedigree, hiring signals, revenue trajectory, and the full cap table.